Guy Archibald Innes is Director at VOLITIONRX LTD (VNRX). They have made 19 open-market trades across 1 company since 2013, most recently 2026-02-26.
CIK 0001579377
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
19 open-market purchases totalling $2.0B since 2013, never a sale. Across 19 scored buys the stock is up 3.1% at ninety days, and 0.2 points behind the S&P over the same stretch.
19 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| VNRX | 1,252,967 | $227K |
Shares reported on the most recent Form 4, priced at the 2026-02-27 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 32% | 42% | 58% |
| Avg Move | -0.7% | -3.7% | +3.1% |
| Alpha | +0.6% | -4.1% | -0.2% |
| Scored | 19 | 19 | 19 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VNRX | BUY | 2025-10-14 | 2025-10-15 | $0.51 | $49K | -5.9% | -28.8% | -32.3% |
| VNRX | BUY | 2025-08-05 | 2025-08-06 | $0.64 | $50K | +0.5% | -11.5% | -34.0% |
| VNRX | BUY | 2025-06-03 | 2025-06-04 | $0.54 | $11K | +27.8% | +20.4% | +18.6% |
| VNRX | BUY | 2025-03-26 | 2025-03-27 | $0.55 | $200K | -13.0% | -12.5% | +43.7% |
| VNRX | BUY | 2024-12-09 | 2024-12-10 | $0.57 | $199K | +15.0% | +10.9% | -1.3% |
| VNRX | BUY | 2024-08-20 | 2024-08-21 | $0.67 | $101K | +6.3% | -1.5% | +0.0% |
| VNRX | BUY | 2023-11-27 | 2023-11-28 | $0.77 | $15K | -20.4% | -17.5% | +22.5% |
| VNRX | BUY | 2023-11-24 | 2023-11-27 | $0.76 | $8K | -13.6% | -6.8% | +28.9% |
| VNRX | BUY | 2023-11-22 | 2023-11-24 | $0.71 | $14K | -9.0% | -8.3% | +27.7% |
| VNRX | BUY | 2023-02-22 | 2023-02-23 | $1.75 | $102K | +9.9% | -5.5% | -15.4% |
| VNRX | BUY | 2022-08-02 | 2022-08-04 | $2.00 | $175K | -2.5% | -16.8% | -4.5% |
| VNRX | BUY | 2022-05-16 | 2022-05-17 | $2.37 | $24K | -8.1% | -22.2% | -25.6% |
| VNRX | BUY | 2021-05-14 | 2021-05-18 | $3.35 | $503K | -3.6% | -8.8% | -13.0% |
| VNRX | BUY | 2018-08-16 | 2018-08-20 | $2.00 | $100K | +25.2% | +28.0% | +31.9% |
| VNRX | BUY | 2015-02-11 | 2015-02-13 | $3.75 | $188K | -4.5% | +2.1% | +2.1% |
| VNRX | BUY | 2014-09-24 | 2014-09-29 | $18748.40 | $159.8M | -4.5% | +2.1% | +2.1% |
| VNRX | BUY | 2014-03-10 | 2014-03-12 | $42294.43 | $1.8B | -4.5% | +2.1% | +2.1% |
| VNRX | BUY | 2013-12-02 | 2013-12-04 | $9999.90 | $48.8M | -4.5% | +2.1% | +2.1% |
| VNRX | BUY | 2013-11-14 | 2013-11-18 | $6922.22 | $40.7M | -4.5% | +2.1% | +2.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.